Navigation Links
Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML Presented at the American Society of Hematology
Date:12/13/2011

BURLINGTON, Mass., Dec. 13, 2011 /PRNewswire/ -- Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that an oral presentation on CNDO-109 was given at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition held at the San Diego Convention Center in California.  CNDO-109 is a biologic that activates natural killer (NK) cells for the treatment of acute myeloid leukemia (AML) and solid tumors.

Dr. Panagiotis Kottaridis of the Department of Haematology, Royal Free Hampstead NHS Trust and University College London Medical School, UK reported the final results of the Phase 1 clinical trial of CNDO-109 in AML (abstract #946).  The results demonstrated that AML patients experienced a longer complete remission (CR) after receiving CNDO-109 activated NK cells than their previous CR.

The analysis was based on eight AML patients of whom five were in a subsequent CR, one was in their first CR, one was in partial relapse (PR) and one was in relapsing disease.  As conditioning, patients received fludarabine 25mg/m2/day for three days plus a single fraction (2Gy) total body irradiation (TBI) on day four.  24 hours after the completion of TBI, patients received 1 million activated haploidentical related donor CNDO-109 tumor primed NK cells as a single i.v. infusion. 

Three of the patients in a subsequent CR demonstrated a longer CR than their previous one, and the patient in PR reverted to CR.  No comparison was available for the patient in their first CR, and the patient in relapsing disease was not evaluable.

No toxicity related to the infusion was observed. Seven patients experienced bone marrow suppression with a median time of 55 days (19-101) for neutrophil recovery.
'/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
2. Coronado Biosciences Closes $25.8M in Series C Financing
3. Coronado Biosciences Files to Become a Public Reporting Company
4. Coronado Biosciences to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
6. Coronado Biosciences Reports Third Quarter 2011 Financial Results
7. Coronado Biosciences Commences Public Trading on the OTC Bulletin Board
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
(Date:9/22/2014)... , Sept. 22, 2014 Arena Pharmaceuticals, Inc. (NASDAQ: ... scheduled to present a corporate overview and update at ... September 26, 2014, at 11:30 a.m. Eastern Time (8:30 ... New York City . ... available under the investor relations section of Arena,s website ...
(Date:9/22/2014)... , September 22, 2014 ... "Cell Line Development Market by Product (Equipment, Media and ... Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, ... 2019", published by MarketsandMarkets, analyzes and studies the ... Browse 114 market data tables and ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
(Date:9/22/2014)... meeting in Valves and Structural Heart, the fifth annual ... the 28th to the 30th of September, 2014 at ... UK. , In the tradition of the pioneering work ... become an accepted clinical option, PCR London Valves is ... and structural heart. Through innovative technologies and their application ...
(Date:9/22/2014)... by the Cancer Science Institute of Singapore (CSI ... found that an increase in a gene known ... implicated in acute myelogenous leukaemia (AML), increasing the ... Professor Chng Wee Joo, Deputy Director and Senior ... the National University Cancer Institute, Singapore, the scientists ...
(Date:9/22/2014)... FL (PRWEB) September 22, 2014 ... than 2,000 physicians, today Clearwater Clinical ... ClearSCOPE Endoscope Adaptor for smartphones. ClearSCOPE ... video from virtually any endoscope and smartphone. , ... adaptor in response to frustrations over the cost, ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 PreDiabetes ... treatment, will work with companies to help employees learn ... development of diabetes as part of a collaboration with ... @ Work initiative. , PreDiabetes Centers Medical Director ... of Transportation in Austin on Tuesday, October 21st to ...
(Date:9/22/2014)... On Saturday, September 27, 2014, La Comunidad ... fitness fair ¡Vive tu vida! Get Up! Get Moving!® This ... better health and wellness for people of all ages and ... the public, will be held at Anson B. Nixon Park, ... 2:00 pm. , “This is a wonderful event each ...
Breaking Medicine News(10 mins):Health News:Announcing the 5th PCR London Valves, 2014 2Health News:Announcing the 5th PCR London Valves, 2014 3Health News:Announcing the 5th PCR London Valves, 2014 4Health News:Singapore researchers discover a gene that increases incidence of AML 2Health News:ClearSCOPE 2.0 Endoscope Adaptor for Smartphones Announced; Endoscopic Video Capture Reinvented 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3
... -- The Human Genome Project, along with numerous parallel efforts ... fungal, and microbe genomes in the last few decades, has ... struggling to keep pace. Knowing gene sequences, after all, may ... actual manifestation of physical traits (or phenotypes) of an organism ...
... ... technical and medical market, announced today that Wiley-Blackwell has agreed to conduct a trial ... three-month trial is designed to test how SciVee products and services can supplement and ... , ...
... five cesareans due to ,failed inductions, researchers find , ... than doubles the risk of having a cesarean delivery, ... numbers to a link that experts have long suspected. ... said study author Dr. Deborah Ehrenthal, director of women,s ...
... ... a gated community on Costa Rica’s South Pacific coast – has announced it will partner ... will be dedicated to helping its residents discover health and rediscover vitality. , ... (PRWEB) June 22, 2010 -- Pegasus Star ...
... ... even sit up straight and then, one day, you,re able to run through a meadow ... the very first time when they join the Hippotherapy and Therapeutic Riding programs at CAN-TR ... and Siler City resident, Lisa Reynolds. , ...
... ... with these budget-conscious instruments. , ... (Vocus) June 22, 2010 -- Cole-Parmer introduces a new line of ... For specialists in process, production, and manufacturing facilities who count parts or add up ...
Cached Medicine News:Health News:New genetic analysis reveals principles of phenotypic expression 2Health News:Wiley-Blackwell Conducts Trial of SciVee Video Platform 2Health News:Wiley-Blackwell Conducts Trial of SciVee Video Platform 3Health News:Labor Induction May Boost C-Section Risk 2Health News:Labor Induction May Boost C-Section Risk 3Health News:Costa Rica Real Estate Project Takes a Holistic Approach to Health Care 2Health News:Costa Rica Real Estate Project Takes a Holistic Approach to Health Care 3Health News:Ponies Help Kids with Disabilities Focus on What They CAN Do 2Health News:Ponies Help Kids with Disabilities Focus on What They CAN Do 3Health News:Cole-Parmer Launches New Industrial Line of Symmetry Scales 2
... is a family of solutions that ... individuals inside hospitals, healthcare facilities, or ... The target tracking areas are networked ... of radio frequency identification (RFID) readers ...
Assetrac allows identification, location, and protection of your assets....
... The RoamAlert Integrity system builds ... ECO. All door controllers in the ... computer running a standard Windows® operating ... the use of a personal computer, ...
... uses RFID to gather patient ... departments such as surgical and ... updates of patient location to ... care events have occurred and ...
Medicine Products: